Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Manuel Moreno Gonzales"'
Autor:
Juan Luis Quintana, Xosse Carreras, Andrea S. Salcedo, Lourdes Torres Ruíz, Manuel Moreno Gonzales, Alfonso Del Castillo Mory, Hugo Cedrón Cheng, Alfredo Chiappe Gonzalez
Publikováno v:
IDCases, Vol 32, Iss , Pp e01794- (2023)
Yeast fungi of the genus Trichosporon spp. can colonize the gastrointestinal tract in humans. In recent decades, the pathogenic role of Trichosporon asahii has been increasingly acknowledged especially in the setting of neutropenic patients with hema
Externí odkaz:
https://doaj.org/article/a00d8d96e94b4ee1ad6fe576a88c67dc
Publikováno v:
Transplantation Reports, Vol 4, Iss 2, Pp - (2019)
Background: Liver transplantation (LT) is the gold standard therapy for end-stage liver diseases (ESLD) worldwide. Over the past decades, multiple strategies have been developed in order to optimize allograft/recipient outcomes and decrease patient m
Externí odkaz:
https://doaj.org/article/ab2335f50fbd4b059824518307fd077f
Autor:
Manuel Moreno Gonzales, Nancy Mayo, Julia Sumire, José Luis Valbuena Durán, Juan Cruzado, Marco Gonzalez, Félix Carrasco, Omar Ponce, Antonio García Sánchez, Marlene Cisneros, Melva Benavides, Carla Mendez, Graciela Navarro, Roxana Lipa
Publikováno v:
Transplantation proceedings. 52(3)
Pediatric kidney transplantation (PKTx) is the preferred therapy for children with end-stage renal disease (ESRD) worldwide. Regrettably, in Perú, access to PKTx is extremely difficult due to recipient/donor socio-economic status, health care struct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f87c42f908bc0b9ea9e45ce1640e03d
https://pubmed.ncbi.nlm.nih.gov/32115239
https://pubmed.ncbi.nlm.nih.gov/32115239
Publikováno v:
Transplantation Reports, Vol 4, Iss 2, Pp-(2019)
Background: Liver transplantation (LT) is the gold standard therapy for end-stage liver diseases (ESLD) worldwide. Over the past decades, multiple strategies have been developed in order to optimize allograft/recipient outcomes and decrease patient m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33ff41182ced4ddcb7f14d756b5a3ee9
http://www.sciencedirect.com/science/article/pii/S2451959619300228
http://www.sciencedirect.com/science/article/pii/S2451959619300228
Publikováno v:
Journal of the American Society of Nephrology. 27:3165-3174
The ability to predict outcomes for individual patients would be a significant advance for not only counseling, but also identifying those for whom interventions may be needed. The goals of this study were to validate an existing risk prediction scor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f89403ead99f1a43859be6f5bdd09cc
https://doi.org/10.1681/asn.2015070811
https://doi.org/10.1681/asn.2015070811
Autor:
Manuel Moreno Gonzales, Patrick G. Dean, Keisha Bonner, Lynn D. Cornell, Carrie A. Schinstock, Alexandre Loupy, Walter D. Park, Carmen Lefaucheur, Richard Borrows, Andrew Bentall, Byron H. Smith, Mark D. Stegall
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 19(8)
Predicting which renal allografts will fail and the likely cause of failure is important in clinical trial design to either enrich patient populations to be or as surrogate efficacy endpoints for trials aimed at improving long-term graft survival. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad7021912b0b87c2cb48507eff7eae2
https://pubmed.ncbi.nlm.nih.gov/30768833
https://pubmed.ncbi.nlm.nih.gov/30768833
Autor:
Mark D. Stegall, Manish J. Gandhi, Manuel Moreno Gonzales, Patrick G. Dean, Andrew Bentall, Loren Paola Herrera, Walter D. Park, Lynn D. Cornell, Jeffrey L. Winters
Publikováno v:
Transplantation. 98:1089-1096
BACKGROUND ABO-incompatible kidney transplantations (ABOiKTxs) seem to have better long-term outcomes than positive crossmatch kidney transplantations (+XMKTxs). METHODS This study aimed to assess the differences in chronic injury on histologic findi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911d51bc55bb2116a78b82dead4b0544
https://doi.org/10.1097/tp.0000000000000188
https://doi.org/10.1097/tp.0000000000000188
Autor:
Carrie A. Schinstock, Nong Y. Braaten, Mark D. Stegall, Natalie Moore, Byron H. Smith, Manuel Moreno Gonzales, Manish J. Gandhi
Publikováno v:
Transplantation. 101(6)
We previously showed that bortezomib (BTZ) partially depletes plasma cells, yet has limited efficacy for desensitization in kidney transplant candidates when up to 16 doses is given. This study aimed to determine the safety and efficacy of 32 doses o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d0e101d632a2870c73150fd0043914
https://pubmed.ncbi.nlm.nih.gov/27379560
https://pubmed.ncbi.nlm.nih.gov/27379560